What is the appropriate treatment approach for a postmenopausal patient with advanced or metastatic hormone receptor-positive, HER2-negative breast cancer, considering Fulvestrant (Fulvestrant) and Ribociclib (Ribociclib) as first-line therapy, and Vinorelbine (Vinorelbine) as a potential later-line option?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board

Educational purpose only • Exercise caution as content is pending human review

Article Review Status

Submitted

Under Review

Approved

Last updated: January 28, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

What are the next steps for a patient with ER (estrogen receptor)-positive, HER2 (human epidermal growth factor receptor 2) 1+, PR (progesterone receptor)-negative advanced breast cancer who is progressing in the liver on ribociclib (Kisqali) (cdk4/6 inhibitor) and fulvestrant (Faslodex) (estrogen receptor antagonist)?

What treatment options are available for a patient with ER+ (estrogen receptor positive) breast cancer who has progressed on ribociclib (Ribociclib) and fulvestrant (Fulvestrant) with liver involvement?

What are the treatment options for a premenopausal patient with stage IV Hormone Receptor positive (HR+), Human Epidermal growth factor Receptor 2 negative (HER2-) breast cancer who has progressed on Ribociclib (CDK4/6 inhibitor) and Fulvestrant (estrogen receptor antagonist) with a Luteinizing Hormone-Releasing Hormone (LHRH) agonist?

At what QTc interval should I withhold ribociclib (cyclin-dependent kinase 4/6 inhibitor)?

What is the comparison between Ribociclib (Kisqali) and MonarchE trials?

What is the initial treatment for acute hypertension in a hospital setting?

Is it appropriate to increase hydroxyzine to 50 mg TID and add low-dose doxepin for a 60-year-old patient with depression, anxiety, and possible Parkinson's disease or restless legs syndrome, taking fluoxetine, bupropion, ropinirole, hydroxyzine, and mirtazapine?

What is the contagious period of chickenpox?

What is the recommended treatment approach for a postmenopausal woman with hormone receptor-positive metastatic breast cancer who has progressed on or after prior endocrine therapy, considering Fulvestrant (Fulvestrant) and Vinorelbine (Vinorelbine)?

What medication adjustments can be made for a geriatric patient with Huntington's disease and dementia, currently on Zyprexa (olanzapine) 2.5mg with additional doses for agitation and daily Lexapro (escitalopram), who is experiencing increased agitation and insomnia, despite previous trial of Doxepin, and has a tube feed?

Is it appropriate to add doxepin to an elderly patient's medication regimen, which includes fluoxetine (40 mg daily), bupropion (300 mg XL), ropinirole (0.5 mg), hydroxyzine (HCl 10 mg, 3 tablets, 3 times daily as needed), and Remeron (mirtazapine 15 mg), for persistent sleep issues despite a recent increase in fluoxetine?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.